LONG-TERM PROGNOSIS AND MODES OF DEATH IN HEART FAILURE PATIENTS WITH REDUCED VERSUS PRESERVED LEFT VENTRICULAR SYSTOLIC FUNCTION

Background: There are conflicting reports regarding the prognosis of heart failure patients with preserved (HFPSF) comparative to reduced systolic left ventricular function (HFRSF). We evaluated the clinical characteristics, mortality rates and modes of death in 309 consecutive symptomatic heart failure patients. In 133(56%) patients LVEF was <50% (HFRSF), and in 133 (44%), LVEF was ≥50% (HFPSF). Methods: Three hundred nine consecutive patients hospitalized between January 1, 2009 and January 1, 2010 (176 men and 133 women, mean age 64.3 years) were followed up for a mean period of 23±14 months. The severity of symptoms at admission was assessed by NYHA classification. 196 patients were in NYHA class I-II, and 113 in III–IV. All patients underwent chest X-ray, echocardiogram, and a 6-minute walking test. We compared the clinical profiles, mortality rates and modes of death. Results: More than a third (44%) of the patients had preserved systolic LVEF based on echocardiography. Compared to the HFPSF group, HFRSF patients were predominantly younger males with ischemic aetiology and less cardiovascular comorbidities such as obesity, hypertension, diabetes mellitus and atrial fibrillation. During a mean follow-up period of 1.9 years, 22 (7.1%) patients died: 14 of cardiac causes and 8 of non-cardiac causes (4 of respiratory causes, 2 of stroke, 1 of major bleeding and 1 of cancer). Overall mortality was similar between the two groups: 8 (6%) in HFPSF patients and 14 (7.9%) in HFRSF patients (p=0.67). HFRSF patients had higher death rates due to pump failure compared to the HFPSF group [ 5/14(36%) vs. 1/8(12%) patients, p=0.5]. Non-cardiac deaths were more frequent in HFPSF group [4/8 (50%) patients vs. 4/14(28%) patients, respectively, p=0.5]. The prevalence of arrhythmic death was similar in the two groups [5/14(36%) vs.3/8(37%) patients, p=0.6]. With Cox stepwise regression analysis for survival, the independent predictors for mortality were age, gender, ischemic etiology of heart failure and renal impairment. Conclusions: Although the characteristics of HFPSF and SHF patients are different, the mortality rates were similar in our study. The mode of death was different among the two groups of patients, as pump failure death rate was higher in patients with LVEF <50%, while non-cardiac death was higher in heart failure patients with preserved systolic function. The differences were not statistically significant. A high NYHA class at admission, age over 65, male gender and renal impairment were related to a worse prognosis.

[1]  G. Berríos,et al.  The Hamilton Depression Scale and the numerical description of the symptoms of depression. , 1990, Psychopharmacology series.

[2]  P. Poole‐Wilson,et al.  Mode of death in heart failure: findings from the ATLAS trial , 2003, Heart.

[3]  D. Burkhoff,et al.  Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? , 2003, Circulation.

[4]  B. Brendorp,et al.  Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. , 2003, European heart journal.

[5]  J. López-Sendón,et al.  The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction , 2004, Cardiovascular Drugs and Therapy.

[6]  Karl Swedberg,et al.  Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients , 2005, Circulation.

[7]  Peter C Austin,et al.  Outcome of heart failure with preserved ejection fraction in a population-based study. , 2006, The New England journal of medicine.

[8]  V. Roger,et al.  Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.

[9]  Nancy M Albert,et al.  Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. , 2007, Journal of the American College of Cardiology.

[10]  Kanu Chatterjee,et al.  Systolic and diastolic heart failure: differences and similarities. , 2007, Journal of cardiac failure.

[11]  E. Colín-Ramírez,et al.  Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients. , 2007, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[12]  B. Lewis,et al.  Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: the Israel Nationwide Heart Failure Survey. , 2007, The Israel Medical Association journal : IMAJ.

[13]  A. Keren,et al.  Clinical outcome of patients with heart failure and preserved left ventricular function. , 2008, The American journal of medicine.

[14]  M. Cowie,et al.  Mode of death in patients with newly diagnosed heart failure in the general population , 2008, European journal of heart failure.

[15]  Z. Massy,et al.  Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. , 2008, European heart journal.

[16]  F. Formiga,et al.  Admission characteristics predicting longer length of stay among elderly patients hospitalized for decompensated heart failure. , 2008, European journal of internal medicine.

[17]  A. Maestre,et al.  Prediction clinical profile to distinguish between systolic and diastolic heart failure in hospitalized patients. , 2009, European journal of internal medicine.

[18]  Y. Ozaki,et al.  Long term prognosis of chronic heart failure: reduced vs preserved left ventricular ejection fraction. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[19]  W. Paulus,et al.  Treatment of heart failure with normal ejection fraction: an inconvenient truth! , 2010, Journal of the American College of Cardiology.

[20]  A. Keren,et al.  Heart Failure and Preserved Left Ventricular Function: Long Term Clinical Outcome , 2012, PloS one.